Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000027

CEO bought 40,000 shares at an average $0.01 ($596)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2019-04-26 Purchase : show line 1 in the form +2,000 $0.01 $30 21,120,123 D
2019-04-26 Purchase : show line 2 in the form +5,000 $0.01 $74 21,125,123 D
2019-04-26 Purchase : show line 3 in the form +10,000 $0.01 $147 21,135,123 D
2019-04-26 Purchase : show line 4 in the form +10,000 $0.01 $148 21,145,123 D
2019-04-26 Purchase : show line 5 in the form +2,000 $0.02 $31 21,147,123 D
2019-04-26 Purchase : show line 6 in the form +5,000 $0.01 $74 21,152,123 D
2019-04-29 Purchase : show line 7 in the form +2,000 $0.02 $32 21,154,123 D
2019-04-29 Purchase : show line 8 in the form +2,000 $0.02 $32 21,156,123 D
2019-04-29 Purchase : show line 9 in the form +2,000 $0.01 $30 21,158,123 D
Open-market purchases · 40,000 sh · avg $0.01 · $596
Loading xslF345X03/primary_doc.xml…